Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures
Neurosurgical Focus · 2023-10 · 55 (4) · E6
DOI: 10.3171/2023.7.focus23357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Focus, 2023-10. Verfasst von Jonathan Rychen und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Thromboembolism. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE Discontinuation of antithrombotics (AT) prior to elective cranial procedures is common practice, despite the higher risk of thromboembolic complications in these patients. The aim of this study was to investigate the risks and benefits of a new perioperative management protocol of continuation or ultra-early AT resumption in elective cranial procedures. METHODS This study was an analysis of a prospectively collected cohort of patients undergoing elective cranial surgery with (AT group) and without (control group) AT. For extraaxial or shunt surgeries, acetylsalicylic acid (ASA) was continued perioperatively. For intraaxial pathologies, ASA was discontinued 2 days before surgery and resumed on postoperative day 3. All other AT were discontinued according to their pharmacokinetics, and resumed on postoperative day 3 after unremarkable postoperative imaging. Additionally, the authors performed a retrospective analysis of patients with AT who underwent surgery before implementation of this new AT management protocol (historical AT group). Primary and secondary outcomes were the incidence of hemorrhagic and thromboembolic complications within 3 months after surgery. RESULTS Outcomes of 312 patients were analyzed (83 [27%] in the AT group, 106 [34%] in the control group, and 123 [39%] in the historical AT group). For all 3 patient groups, the most common type of surgery was craniotomy for intraaxial tumors (14 [17%] in the AT group, 28 [26%] in the control group, and 60 [49%] in the historical AT group). The most commonly used AT were ASA (38 [46%] in the AT group and 78 [63%] in the historical AT group), followed by non–vitamin K oral anticoagulants (32 [39%] in the AT group and 18 [15%] in the historical AT group). The total perioperative discontinuation time in the AT group was significantly shorter than in the historical AT group (median of 4 vs 16 days; p < 0.001). The rate of hemorrhagic complications was 4% (95% CI 1–10) (n = 3/83) in the AT group, 6% (95% CI 2–12) (n = 6/106) in the control group, and 7% (95% CI 3–13) (n = 9/123) in the historical AT group (p = 0.5). The rate of thromboembolic complications was 5% (95% CI 1–12) (n = 4/82) in the AT group, 8% (95% CI 3–15) (n = 8/104) in the control group, and 7% (95% CI 3–13) (n = 8/120) in the historical AT group (p = 0.7). CONCLUSIONS The presented perioperative management protocol of continuation or ultra-early resumption of AT in elective cranial procedures does not seem to increase the hemorrhagic risk. Moreover, it appears to potentially protect patients from thromboembolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Neurosurgery.
- 2Surgical Outcome Research Center Basel.
- 4Faculty of Medicine, University of Basel, Switzerland.
- 3Department of Clinical Studies, University Hospital of Basel; and.
Zitieren
APA
Rychen, J., Weiger, V. F., Halbeisen, F. S., Ebel, F., Ullmann, M., Mariani, L., Guzman, R., & Soleman, J. (2023). Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures. Neurosurgical Focus, 55(4), E6. https://doi.org/10.3171/2023.7.focus23357
Vancouver
Rychen J, Weiger VF, Halbeisen FS, Ebel F, Ullmann M, Mariani L, et al. Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures. Neurosurgical Focus. 2023;55(4):E6. doi:10.3171/2023.7.focus23357
BibTeX
@article{Rychen2023,
author = {Rychen, Jonathan and Weiger, Valentin F and Halbeisen, Florian S and Ebel, Florian and Ullmann, Muriel and Mariani, Luigi and Guzman, Raphael and Soleman, Jehuda},
title = {Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures},
journal = {Neurosurgical Focus},
year = {2023},
volume = {55},
number = {4},
pages = {E6},
doi = {10.3171/2023.7.focus23357}
}
EUVIMED